Publication | Open Access
Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-ɣ and NF-kB mechanism
63
Citations
28
References
2021
Year
We propose methoxyeugenol as a novel and potential therapeutic approach to treat chronic liver disease and fibrosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1